This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignees: Centre National De La Recherche Scientifique, Universitè De Montpellier. Active years: 2026.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 138 
1 out of 298 
Years Active: 2026
Title: Gaël Petitjean - Innovator in Viral Reservoir Evaluation
Introduction: Gaël Petitjean is an inventor based in Montpellier, France. He is associated with the Centre National de la Recherche Scientifique, where he contributes to research and innovation. Although he currently holds no granted patents, his work focuses on significant advancements in the evaluation of viral reservoirs.
Latest Patent Applications: Gaël Petitjean's notable patent application is titled "Method for Evaluating the Presence of a Viral Reservoir, and Evaluating the Efficacy of a Drug Against Said Reservoir." This method aims to evaluate the efficacy of a drug designed to eradicate a cellular reservoir of mammalian cells infected with a mammalian immunodeficiency virus. The process includes quantifying the presence of lymphocyte cells that express a CD32 differentiation marker on their surface. The conclusion drawn is that the drug is effective in eradicating the cellular reservoir when lymphocyte cells expressing the CD32a differentiation marker are absent.
Conclusion: Gaël Petitjean's innovative approach to evaluating viral reservoirs highlights his commitment to advancing medical research. His contributions, particularly in the realm of drug efficacy evaluation, are essential for future developments in combating viral infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile